Schüler Thomas, Mesic Ivana, Madry Christian, Bartholomäus Ingo, Laube Bodo
Max-Planck-Institut für Hirnforschung, Frankfurt 60528 Germany; Technische Universität Darmstadt, AG Molekulare und zelluläre Neurophysiologie, Schnittspahnstrasse 3, Darmstadt 64287, Germany.
Max-Planck-Institut für Hirnforschung, Frankfurt 60528 Germany.
J Biol Chem. 2008 Jan 4;283(1):37-46. doi: 10.1074/jbc.M703539200. Epub 2007 Oct 24.
N-Methyl-D-aspartate (NMDA) receptors are tetrameric protein complexes composed of the glycine-binding NR1 subunit with a glutamate-binding NR2 and/or glycine-binding NR3 subunit. Tri-heteromeric receptors containing NR1, NR2, and NR3 subunits reconstitute channels, which differ strikingly in many properties from the respective glycine- and glutamate-gated NR1/NR2 complexes and the NR1/NR3 receptors gated by glycine alone. Therefore, an accurate oligomerization process of the different subunits has to assure proper NMDA receptor assembly, which has been assumed to occur via the oligomerization of homodimers. Indeed, using fluorescence resonance energy transfer analysis of differentially fluorescence-tagged subunits and blue native polyacrylamide gel electrophoresis after metabolic labeling and affinity purification revealed that the NR1 subunit is capable of forming homo-oligomeric aggregates. In contrast, both the NR2 and the NR3 subunits formed homo- and hetero-oligomers only in the presence of the NR1 subunit indicating differential roles of the subunits in NMDA receptor assembly. However, co-expression of the NR3A subunit with an N-terminal domain-deleted NR1 subunit (NR1(DeltaNTD)) abrogating NR1 homo-oligomerization did not affect NR1/NR3A receptor stoichiometry or function. Hence, homo-oligomerization of the NR1 subunit is not essential for proper NR1/NR3 receptor assembly. Because identical results were obtained for NR1(DeltaNTD)/NR2 NMDA receptors (Madry, C., Mesic, I., Betz, H., and Laube, B. (2007) Mol. Pharmacol., 72, 1535-1544) and NR1-containing hetero-oligomers are readily formed, we assume that heterodimerization of the NR1 with an NR3 or NR2 subunit, which is followed by the subsequent association of two heterodimers, is the key step in determining proper NMDA receptor subunit assembly and stoichiometry.
N-甲基-D-天冬氨酸(NMDA)受体是由甘氨酸结合型NR1亚基与谷氨酸结合型NR2和/或甘氨酸结合型NR3亚基组成的四聚体蛋白复合物。含有NR1、NR2和NR3亚基的三聚体受体重构通道,其在许多特性上与各自的甘氨酸门控和谷氨酸门控NR1/NR2复合物以及仅由甘氨酸门控的NR1/NR3受体显著不同。因此,不同亚基的精确寡聚化过程必须确保NMDA受体的正确组装,这被认为是通过同型二聚体的寡聚化发生的。事实上,使用差异荧光标记亚基的荧光共振能量转移分析以及代谢标记和亲和纯化后的蓝色天然聚丙烯酰胺凝胶电泳表明,NR1亚基能够形成同型寡聚聚集体。相比之下,NR2和NR3亚基仅在NR1亚基存在的情况下形成同型和异型寡聚体,这表明亚基在NMDA受体组装中具有不同的作用。然而,将NR3A亚基与N端结构域缺失的NR1亚基(NR1(DeltaNTD))共表达以消除NR1同型寡聚化,并不影响NR1/NR3A受体的化学计量或功能。因此,NR1亚基的同型寡聚化对于正确的NR1/NR3受体组装并非必不可少。因为对于NR1(DeltaNTD)/NR2 NMDA受体也得到了相同的结果(Madry, C., Mesic, I., Betz, H., and Laube, B. (2007) Mol. Pharmacol., 72, 1535 - 1544),并且含有NR1的异型寡聚体很容易形成,我们假设NR1与NR3或NR2亚基的异源二聚化,随后两个异源二聚体的后续缔合,是决定正确的NMDA受体亚基组装和化学计量的关键步骤。